Recessive mutations in the last exon of MYL2 cause a novel, lethal infantile cardioskeletal myopathy characterized by dilated cardiomyopathy and muscle type I hypotrophy.
No takes yet. Share an insight, caveat, or question.
May inform genetic diagnosis in lethal infantile cardioskeletal myopathy; leaves open prevalence and therapeutic implications pending additional cases.
Weterman et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: